GELESIS HOLDINGS, INC.

Gelesis Holdings, Inc. filed an 8-K on January 20, 2022, corresponding to the close of its de-SPAC transaction with Capstar Special Purpose Acquisition Corp, which traded under the ticker CPSR. Capstar, sponsored by Capstar SPAC Sponsor LLC, completed its IPO in 2020 and targeted the healthcare and life sciences sector. Gelesis is a commercial-stage biotech company focused on treatments for chronic diseases linked to excess body weight, best known for its superabsorbent hydrogel product Plenity. The combined entity, operating as Gelesis Holdings, listed on the New York Stock Exchange following the merger. Sign up at SpacDesk for complete filings, timeline data, and sponsor analytics on this and every active SPAC transaction.